These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 18649402)

  • 21. Constitutive androstane receptor upregulates Abcb1 and Abcg2 at the blood-brain barrier after CITCO activation.
    Lemmen J; Tozakidis IE; Bele P; Galla HJ
    Brain Res; 2013 Mar; 1501():68-80. PubMed ID: 23340159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of major efflux transporters under inflammatory conditions at the blood-brain barrier in vitro.
    von Wedel-Parlow M; Wölte P; Galla HJ
    J Neurochem; 2009 Oct; 111(1):111-8. PubMed ID: 19656257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Membrane transporter proteins: a challenge for CNS drug development.
    Girardin F
    Dialogues Clin Neurosci; 2006; 8(3):311-21. PubMed ID: 17117613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of ATP-binding cassette transporters on human immunodeficiency virus therapy.
    Weiss J; Haefeli WE
    Int Rev Cell Mol Biol; 2010; 280():219-79. PubMed ID: 20797684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of ATP-binding cassette membrane transporters in a HIV-1 transgenic rat model.
    Robillard KR; Hoque MT; Bendayan R
    Biochem Biophys Res Commun; 2014 Feb; 444(4):531-6. PubMed ID: 24472536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human ABC transporters at blood-CNS interfaces as determinants of CNS drug penetration.
    Chaves C; Shawahna R; Jacob A; Scherrmann JM; Declèves X
    Curr Pharm Des; 2014; 20(10):1450-62. PubMed ID: 23789951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of HIV-1 Tat and Methamphetamine on Blood-Brain Barrier Integrity and Function
    Patel S; Leibrand CR; Palasuberniam P; Couraud PO; Weksler B; Jahr FM; McClay JL; Hauser KF; McRae M
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioligands targeting P-glycoprotein and other drug efflux proteins at the blood-brain barrier.
    Wanek T; Mairinger S; Langer O
    J Labelled Comp Radiopharm; 2013; 56(3-4):68-77. PubMed ID: 24285312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters.
    Kis O; Robillard K; Chan GN; Bendayan R
    Trends Pharmacol Sci; 2010 Jan; 31(1):22-35. PubMed ID: 20004485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.
    Lazarowski A; Czornyj L; Lubienieki F; Girardi E; Vazquez S; D'Giano C
    Epilepsia; 2007; 48 Suppl 5():140-9. PubMed ID: 17910594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals.
    Pal D; Kwatra D; Minocha M; Paturi DK; Budda B; Mitra AK
    Life Sci; 2011 May; 88(21-22):959-71. PubMed ID: 20932495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidrug resistance-associated proteins: expression and function in the central nervous system.
    Dallas S; Miller DS; Bendayan R
    Pharmacol Rev; 2006 Jun; 58(2):140-61. PubMed ID: 16714484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative evaluation of the impact of active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier on the predictability of the unbound concentrations of drugs in the brain using cerebrospinal fluid concentration as a surrogate.
    Kodaira H; Kusuhara H; Fujita T; Ushiki J; Fuse E; Sugiyama Y
    J Pharmacol Exp Ther; 2011 Dec; 339(3):935-44. PubMed ID: 21934030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efflux mechanisms at the developing brain barriers: ABC-transporters in the fetal and postnatal rat.
    Ek CJ; Wong A; Liddelow SA; Johansson PA; Dziegielewska KM; Saunders NR
    Toxicol Lett; 2010 Aug; 197(1):51-9. PubMed ID: 20466047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
    Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
    World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.
    Assaraf YG
    Drug Resist Updat; 2006; 9(4-5):227-46. PubMed ID: 17092765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.
    Leslie EM; Deeley RG; Cole SP
    Toxicol Appl Pharmacol; 2005 May; 204(3):216-37. PubMed ID: 15845415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protease inhibitors atazanavir, lopinavir and ritonavir are potent blockers, but poor substrates, of ABC transporters in a broad panel of ABC transporter-overexpressing cell lines.
    Bierman WF; Scheffer GL; Schoonderwoerd A; Jansen G; van Agtmael MA; Danner SA; Scheper RJ
    J Antimicrob Chemother; 2010 Aug; 65(8):1672-80. PubMed ID: 20551216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opioid transport by ATP-binding cassette transporters at the blood-brain barrier: implications for neuropsychopharmacology.
    Tournier N; Declèves X; Saubaméa B; Scherrmann JM; Cisternino S
    Curr Pharm Des; 2011; 17(26):2829-42. PubMed ID: 21827411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRP (ABCC) transporters-mediated efflux of anti-HIV drugs, saquinavir and zidovudine, from human endothelial cells.
    Eilers M; Roy U; Mondal D
    Exp Biol Med (Maywood); 2008 Sep; 233(9):1149-60. PubMed ID: 18535159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.